Innovative Psilocin-Derived Therapies for Rejuvenation
Founded in 2025 by Founders with 300+ patents, combined.
We develop next-generation regenerative therapeutics based on localized delivery of serotonergic compounds.
Our work builds on emerging scientific evidence while prioritizing safety, compliance and intellectual property protection.
Pioneering Psilocin-Based Regeneration
Discover how Phoenix BioTech advances aging reversal with innovative regenerative solutions and groundbreaking research.
2026
Founders’ Vision
Founders with over 300 granted patents, shaping the future of non-psychoactive therapeutic science.
11
Innovative Delivery Paths
Developing controlled, localized treatments across multiple pathways for effective rejuvenation.
9
Collaborative Growth
Seeking partnerships to propel proprietary formulations from research to market impact.
Advancing Regeneration through Targeted Psilocin Science
